Jump to content

Ronald Levy (scientist)

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Chris the speller (talk | contribs) at 13:24, 23 June 2023 (→Education: replaced: Biochemistry → biochemistry). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ronald Levy
Alma mater
Known forRituxan
Children3
Awards2016 AACR-CRI Lloyd J. Old Award in Cancer Immunology
Scientific career
FieldsOncology
Institutions

Ronald Levy is an American medical doctor and scientist at Stanford University. He specializes in lymphoma, including non-Hodgkin lymphoma, Burkitt's lymphoma and Hodgkin's disease.[1] His research investigates how the immune system can be harnessed to fight lymphoma. His work has led to the concept that antibodies can be used as personalized anticancer drugs and to the development of an antibody-based drug, Rituxan, that is widely used to treat lymphoma.[2]

Personal

He is currently married and has 3 daughters.[citation needed]

Education

Levy received an A.B. degree in biochemistry from Harvard University in 1963, and an M.D. from the Stanford University School of Medicine in 1968.[3] He did his residency and internship at the Massachusetts General Hospital, and is board-certified in oncology by the American Board of Internal Medicine.

Honors and awards

Levy's work has been recognized with multiple honors and awards, including the King Faisal International Prize,[4] the Damashek Prize, the American Cancer Society's Medal of Honor, the Leukemia and Lymphoma Society's di Villiers International Achievement Award, the C. Chester Stock Award from the Memorial Sloan Kettering Cancer Center, the Karnofsky Award from the American Society of Clinical Oncology, and others. He is a member of the National Academy of Sciences and of the Institute of Medicine.[5]

King Faisal International Prize in Medicine

In 2009 Levy was awarded the King Faisal International Prize in Medicine, sometimes called the "Arab Nobel Prize". He was awarded the prize for his work on Rituxan. In an interview with Haaretz, Levy said that he was very surprised when he was notified by the prize committee about his victory. He was awarded $200,000, a medal, and a certificate in English and Arabic. He and his family were invited to visit Saudi Arabia and have dinner with the Saudi King Abdullah. Levy's wife is Israeli and one of his daughters was born in Israel, yet his family and he were able to travel to Saudi Arabia with no problems. They were "treated to royal hospitality." Coincidentally, the King Faisal International Prize was first awarded 30 years ago, around the same time that Levy began his work in this field.[6][7] However, despite these statements by Dr. Levy, the King Faisal Award had been awarded previously to individuals who happened to be Jews without any controversy, a notable example being Sydney Brenner who won the award in 1992.

See also

References

  1. ^ "Clinical Focus". Retrieved 2010-02-26.
  2. ^ "A drug of one's own" (PDF). Retrieved 2010-04-02.
  3. ^ "Professional Education". Retrieved 2010-02-26.
  4. ^ "Winners of the King Faisal International Prize (KFIP) for the year 1429H / 2009G". King Faisal Foundation. Retrieved 2010-04-02.
  5. ^ "Honors and Awards". Retrieved 2010-02-26.
  6. ^ "U.S. professor becomes first Jew to win 'Arab Nobel Prize'". 2009-04-16. Retrieved 2010-02-26.
  7. ^ "Jewish oncologist accepts prestigious award from Saudis". 2009-04-23. Retrieved 2010-02-26.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Ronald_Levy_(scientist)&oldid=1161552488"